Asiry Saeed, Fatyan Alaaeddin, Matloob Ammar, Khader Samer N
The Leopold G. Koss Division of Cytopathology, Montefiore Hospital and Medical Center/Albert Einstein College of Medicine, New York, New York, USA.
Diagn Cytopathol. 2020 Aug;48(8):813-815. doi: 10.1002/dc.24453. Epub 2020 May 12.
The COVID-19 pandemic is posing a worldwide challenge to control and contain. SARS-CoV-2 is a highly infectious virus. Health care providers at the front lines are at high risk of getting the infection and the risk applies also to laboratory personnel as they deal with specimens that might be contaminated with infectious materiel. Cytopathology teams specifically are at high risk of dealing with contaminated material because of patients encounter during fine-needle aspiration biopsies or Rapid On-Site Evaluation (ROSE) for adequacy. In our article, we discuss alternative safer staining methods to the widely used Diff-Quick stain that can be utilized for ROSE to decrease the risk of viral exposure during the current COVID-19 pandemic.
新冠疫情对控制和遏制构成了全球性挑战。严重急性呼吸综合征冠状病毒2（SARS-CoV-2）是一种高传染性病毒。一线医护人员感染风险很高，实验室人员在处理可能被传染性物质污染的标本时也面临同样风险。由于在细针穿刺活检或快速现场评估（ROSE）以确定标本充足性过程中会接触患者，细胞病理学团队尤其面临处理污染材料的高风险。在我们的文章中，我们讨论了可用于ROSE的替代更安全染色方法，以替代广泛使用的Diff-Quick染色法，从而在当前新冠疫情期间降低病毒暴露风险。
